Condition

Lymphocytic Leukemia, Chronic (1)

Lymphoma, Non Hodgkin (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Genentech, Inc. (1)

Collaborator

Intervention

atezolizumab (1)

btct4465a (mosunetuzumab) iv (1)

btct4465a (mosunetuzumab) sc (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

lymphoma, non hodgkin

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin Trial in Worldwide (BTCT4465A (Mosunetuzumab) IV, Atezolizumab, BTCT4465A

Recruiting

Lymphocytic Leukemia, Chronic
Lymphoma, Non Hodgkin

BTCT4465A (Mosunetuzumab) IV
+2 more

Duarte, California
+55 more

Aug 4, 2022